Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Round Table with Drs. Blumenschein and Curran, Bulky Stage IIIB NSCLC
Author
Howard (Jack) West, MD

Here is the third and final case I discussed with two great experts in locally advanced NSCLC. Drs. George Blumenschein, medical oncologist from MD Anderson Cancer Center in Houston, and Wally Curran, radiation oncologist from Winship Cancer Center at Emory University in Atlanta, joined me several weeks ago to discuss a series of challenging cases that illustrate the complexities and array of options in treating patients with stage III NSCLC.

This case is a woman with bulky stage IIIB NSCLC that involves lymph nodes above the collarbone (supraclavicular lymph nodes) on both sides, putting her in the outer reaches of what we could envision being treated for cure. Our discussion includes consideration of the potential approaches, including the potential value of chemo before or after concurrent chemo and radiation. It also covers the difficulty of assessing response after treatment, and the risk of radiation pneumonitis.

case-round-table-bulky-stage-iiib-nsclc-drs-blumenschein-and-curran-audio-podcast

case-round-table-bulky-stage-iiib-nsclc-drs-blumenschein-and-curran-figures

case-round-table-bulky-stage-iiib-nsclc-drs-blumenschein-and-curran-transcript

This program was made possible by a grant from OSI Pharmaceuticals. We are grateful for their support.

Next Previous link

Previous PostNext Post

Related Content

Article
Las biopsias líquidas están revolucionando la forma en que combatimos el cáncer, ofreciendo un futuro donde la detección y el tratamiento son más rápidos, precisos y menos invasivos.
Image
Videoteca de Cáncer de Pulmon - 2025
Video
Como parte de la Videoteca de Cáncer de Pulmón en Español 2025, oncólogos expertos discuten las opciones de tratamiento y la información más emergente en cáncer de pulmón. El Dr. Raez aborda la terapia para cánceres de pulmón EGFR y ALK, además de analizar otros tres temas de actualidad. La Dra. Viola y la Dra. Riaño también contribuyen a esta videoteca, cada una presentando tres temas relevantes sobre el cáncer de pulmón.
Article
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.